Skip to main content

CORRECTION article

Front. Microbiol., 15 February 2024
Sec. Antimicrobials, Resistance and Chemotherapy
Volume 15 - 2024 | https://doi.org/10.3389/fmicb.2024.1382491

Corrigendum: ESKAPEE pathogens newly released from biofilm residence by a targeted monoclonal are sensitized to killing by traditional antibiotics

This article is a correction to:

  1. ESKAPEE pathogens newly released from biofilm residence by a targeted monoclonal are sensitized to killing by traditional antibiotics

    1. Read original article
\r\nNikola KurbatfinskiNikola Kurbatfinski1Cameron N. KramerCameron N. Kramer1Steven D. Goodman,Steven D. Goodman1,2Lauren O. Bakaletz, Lauren O. Bakaletz1,2*
  • 1Center for Microbial Pathogenesis, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, United States
  • 2Department of Pediatrics, The Ohio State University College of Medicine, Columbus, OH, United States

A corrigendum on
ESKAPEE pathogens newly released from biofilm residence by a targeted monoclonal are sensitized to killing by traditional antibiotics

by Kurbatfinski, N., Kramer, C. N., Goodman, S. D., and Bakaletz, L. O. (2023). Front. Microbiol. 14:1202215. doi: 10.3389/fmicb.2023.1202215

In the published article, there was an error in the Funding statement. The funding statement is missing credit to the National Institutes of Health for a grant awarded to the corresponding author. Grant NIH R01DC003915 to LB should be added to the funding statement. The correct Funding statement appears below.

Funding

The study received support from cooperative agreement number IDSEP160030 from ASPR/BARDA, as well as awards from the Wellcome Trust and Germany's Federal Ministry of Education and Research (BMBF). This study was funded by Clarametyx Biosciences, Inc., under a sponsored research agreement to LB and SG and NIH R01DC003915 to LB. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: AMR, MRSA, humanized monoclonal antibody, DNABII proteins, tip-chimer peptide

Citation: Kurbatfinski N, Kramer CN, Goodman SD and Bakaletz LO (2024) Corrigendum: ESKAPEE pathogens newly released from biofilm residence by a targeted monoclonal are sensitized to killing by traditional antibiotics. Front. Microbiol. 15:1382491. doi: 10.3389/fmicb.2024.1382491

Received: 05 February 2024; Accepted: 06 February 2024;
Published: 15 February 2024.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2024 Kurbatfinski, Kramer, Goodman and Bakaletz. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Lauren O. Bakaletz, lauren.bakaletz@nationwidechildrens.org

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.